Europharma Rachtansp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 205 days for 2024).
- 2025not filed
- 202405/02/2026
- 202305/08/2024
- 202215/07/2023
- 202118/11/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
- Printing and service activities related to printing (18.1)
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company may be represented by the President of the Management Board and the Vice-President of the Management Board, each of them independently; however, in the event of the appointment of a member of the management board and/or a commercial proxy, the company may be represented by the President of the Management Board and the Vice-President of the Management Board, each of them independently, or by two members of the management board acting jointly, or by a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 26 | $702.32 | 52% | |
Lars Peter Almgren-Rachtan | 24 | $648.30 | 48% |
Agnieszka Elżbieta Almgren Rachtan and Lars Peter Almgren Rachtan hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-07-25.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 27, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $314$314 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Katowice | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $162$162 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sieć Badawcza Łukasiewicz – Instytut Sztucznej Inteligencji I CyberbezpieczeństwaResearch institute | $6,514,456.26 | ai.lukasiewicz.gov.pl | ||
| SR Roboticssp. z o.o. | $4,456,035.13 | srrobotics.pl | ||
| ProgresjaS.A. | $1,461,322.62 | progresja.co | ||
| Clinical Medical Researchsp. z o.o. | $1,047,450.44 | clinicalmedicalresearch.pl | ||
| Specjalistyczne Techniki Izolacyjnesp. z o.o. | $838,388.03 | sti-izolacje.pl | ||
| Clinic Bbpsp. z o.o. | $0.00 | clinicbbp.com | ||
| Kopiltechsp. z o.o. | – | kopiltech.pl | ||
| TXTsp. z o.o. | – | x-or.pl | ||
| Adapt-Esp. z o.o. | – | adapt-e.com | ||
| Blancsp. z o.o. | – | blanc.pl |
FAQ
Last updated: 2026-03-24